Skip to main content

Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia.

Publication ,  Journal Article
Stryjewski, ME; Barriere, SL; Rubinstein, E; Genter, FC; Lentnek, AL; Magana-Aquino, M; Luna, CM; Niederman, MS; Torres, A; Corey, GR
Published in: Int J Antimicrob Agents
October 2013

Duke Scholars

Published In

Int J Antimicrob Agents

DOI

EISSN

1872-7913

Publication Date

October 2013

Volume

42

Issue

4

Start / End Page

367 / 369

Location

Netherlands

Related Subject Headings

  • Vancomycin
  • Treatment Outcome
  • Pneumonia, Bacterial
  • Microbiology
  • Lipoglycopeptides
  • Humans
  • Cross Infection
  • Bacteremia
  • Anti-Bacterial Agents
  • Aminoglycosides
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Stryjewski, M. E., Barriere, S. L., Rubinstein, E., Genter, F. C., Lentnek, A. L., Magana-Aquino, M., … Corey, G. R. (2013). Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia. Int J Antimicrob Agents, 42(4), 367–369. https://doi.org/10.1016/j.ijantimicag.2013.06.003
Stryjewski, Martin E., Steven L. Barriere, Ethan Rubinstein, Fredric C. Genter, Arnold L. Lentnek, Martin Magana-Aquino, Carlos M. Luna, Michael S. Niederman, Antoni Torres, and G Ralph Corey. “Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia.Int J Antimicrob Agents 42, no. 4 (October 2013): 367–69. https://doi.org/10.1016/j.ijantimicag.2013.06.003.
Stryjewski ME, Barriere SL, Rubinstein E, Genter FC, Lentnek AL, Magana-Aquino M, et al. Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia. Int J Antimicrob Agents. 2013 Oct;42(4):367–9.
Stryjewski, Martin E., et al. “Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia.Int J Antimicrob Agents, vol. 42, no. 4, Oct. 2013, pp. 367–69. Pubmed, doi:10.1016/j.ijantimicag.2013.06.003.
Stryjewski ME, Barriere SL, Rubinstein E, Genter FC, Lentnek AL, Magana-Aquino M, Luna CM, Niederman MS, Torres A, Corey GR. Telavancin versus vancomycin for bacteraemic hospital-acquired pneumonia. Int J Antimicrob Agents. 2013 Oct;42(4):367–369.

Published In

Int J Antimicrob Agents

DOI

EISSN

1872-7913

Publication Date

October 2013

Volume

42

Issue

4

Start / End Page

367 / 369

Location

Netherlands

Related Subject Headings

  • Vancomycin
  • Treatment Outcome
  • Pneumonia, Bacterial
  • Microbiology
  • Lipoglycopeptides
  • Humans
  • Cross Infection
  • Bacteremia
  • Anti-Bacterial Agents
  • Aminoglycosides